Tweenvest Stocks

Avenue Therapeutics, Inc. (OTCPK: ATXI)

Health Care · Pharmaceuticals · US

$0.26

+0.98% today · -55.4% 1Y

Avenue Therapeutics, Inc. (OTCPK: ATXI) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $848.78K and employs 1 people.

Over the last twelve months the share price has lost 55.4%, trading between 0.15 and 0.97.

Tweenvest scores Avenue Therapeutics, Inc. across four factors: quality 26/100. Its strongest factor is quality.

ATXI price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$848.78K
Revenue (TTM)
$0.00
P/E
EPS
-0.86
Dividend yield
Beta (5Y)
-0.20
52-week high
$0.97
52-week low
$0.15
Avg volume (3M)
Shares outstanding
3.29M
Employees
1
Next earnings

About Avenue Therapeutics, Inc.

Avenue Therapeutics, Inc. functions as a specialized pharmaceutical enterprise, primarily dedicated to innovating and bringing to market medical therapies tailored for critical and intensive care environments within hospitals. Their leading product candidate is intravenous Tramadol, a synthetic opioid with a dual mechanism of action, currently undergoing Phase III clinical trials for the management of severe pain experienced by patients after surgery. Established in 2015, the company's operations are based in New York, New York.

ISIN
US05360L4032
Founded
2015
Listed since
Jun 27, 2017
Exchange
Pink Sheets LLC
Currency
USD
CompanyMarket capPriceDay
Eli Lilly and CompanyNYSE: LLY$1.12T$1,255.40+0.88%
Johnson & JohnsonNYSE: JNJ$651.25B$270.24+1.07%
Merck & Co., Inc.NYSE: MRK$376.37B$152.55+2.39%
Roche Holding AGSWX: ROP$373.91BCHF375.60+1.02%
Novartis AGSWX: NOVN$302.17BCHF127.42+0.85%
AstraZeneca PLCLSE: AZN$258.76B£122.40+1.26%
Novo Nordisk A/SCPSE: NOVO B$207.84BDkr300.85+1.59%
Pfizer Inc.NYSE: PFE$159.99B$28.07+1.01%

Browse every Pharmaceuticals company →

Figures last refreshed Aug 18, 2026.